Related references
Note: Only part of the references are listed.Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States
Bruce Bode et al.
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2020)
ISPAD Clinical Practice Consensus Guidelines 2018: Management of cystic fibrosis-related diabetes in children and adolescents
Antoinette Moran et al.
PEDIATRIC DIABETES (2018)
Long-Term Follow-Up in a Girl with Cystic Fibrosis and Diabetes Since the First Year of Life
Valentina Fattorusso et al.
DIABETES THERAPY (2017)
Long-Term Follow-Up in a Girl with Cystic Fibrosis and Diabetes Since the First Year of Life
Valentina Fattorusso et al.
DIABETES THERAPY (2017)
Screening of glucose metabolism derangements in pediatric cystic fibrosis patients: how, when, why
Adriana Franzese et al.
ACTA DIABETOLOGICA (2015)
Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status
Moran Lavie et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2015)
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
C. E. Wainwright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Management of cystic fibrosis-related diabetes in children and adolescents
Antoinette Moran et al.
PEDIATRIC DIABETES (2014)
Once daily insulin detemir in cystic fibrosis with insulin deficiency
Shihab Hameed et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2012)
Glucose Derangements in Very Young Children With Cystic Fibrosis and Pancreatic Insufficiency
Enza Mozzillo et al.
DIABETES CARE (2012)
Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial
Laura Minicucci et al.
PEDIATRIC DIABETES (2012)
Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study
Stanislava Kolouskova et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2011)
Cystic Fibrosis Related Diabetes (CFRD)-The End Stage of Progressive Insulin Deficiency
Shihab Hameed et al.
PEDIATRIC PULMONOLOGY (2011)
Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society
Antoinette Moran et al.
DIABETES CARE (2010)
Oral glucose tolerance testing in children with cystic fibrosis
Katie Larson Ode et al.
PEDIATRIC DIABETES (2010)
Cystic Fibrosis-Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality
Antoinette Moran et al.
DIABETES CARE (2009)
One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements
Enza Mozzillo et al.
PEDIATRIC DIABETES (2009)
Growth in Children With Cystic Fibrosis-Related Diabetes
M. S. Cheung et al.
PEDIATRIC PULMONOLOGY (2009)
Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance
C Bizzarri et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2006)
Can glargine reduce the number of lung infections in patients with cystic fibrosis-related diabetes?
A Franzese et al.
DIABETES CARE (2005)
Predictors of deterioration of lung function in cystic fibrosis
C Schaedel et al.
PEDIATRIC PULMONOLOGY (2002)
The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis
P Ripa et al.
CLINICAL ENDOCRINOLOGY (2002)
Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus
S Nousia-Arvanitakis et al.
ACTA PAEDIATRICA (2001)
Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline
CE Milla et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
